Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Polycystic Ovary Syndrome 2 Obesity 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1 Lymphoma 1 Lung Neoplasms 1 Localized Prostate Cancer 1 Leukemia 1 Leiomyosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 4 Specimen Handling 4 Proton Therapy 3 Bevacizumab 3 gallium Ga 68 dotatate 2 abemaciclib 2 Protons 2 Observation 2 Ga(III)-DOTATOC 2 Everolimus 2 Elasticity Imaging Techniques 2 trametinib 1 regorafenib 1 pembrolizumab 1 olaparib 1 neratinib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 brigatinib 1 auricularum 1 apatinib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1 Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × Tablets × Clear all

NCT06275919 2026-05-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡